Pediatric Research
Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma
The benefits and harms of adding long-acting muscarinic antagonists (LAMAs) to inhaled corticosteroids (ICS) and long-acting β2-agonists (LABAs) for moderate